The relationship of the presence, absence or extent of intramedullary T2 signal change to clinical myelopathy, and to the likely outcome after surgery, remains complex and controversial.

More recent publications tend to indicate that T2 weighted signal change, particularly if multisegmental, is a poor prognostic feature for response to surgery.